Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular DNA double-strand break (DSB) induction refers to the creation of breaks in both strands of the DNA helix. These breaks can arise from exogenous sources like radiation and chemicals, or endogenously during DNA replication, meiosis, and immune system development. DSBs are highly cytotoxic and can lead to chromosomal instability, cell death, or tumorigenesis if not properly repaired. The DNA Damage Response (DDR) network detects and orchestrates repair through pathways like homologous recombination (HRR) and non-homologous end joining (NHEJ). Unrepaired or misrepaired DSBs can result in chromosomal rearrangements, mutations, and oncogenic translocations.
Various mechanisms depending on the inducing agent, including direct DNA cleavage, generation of reactive oxygen species, and interference with DNA replication/repair.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular DNA Double-Strand Break Induction (DSB Induction).